Filter By
- Agency-Based Community Benefit (ABCB)
- (-) Behavioral Health Reform and Investment Act Senate Bill 3 (SB3)
- Beneficiary Advisory Council (BAC)
- Child Support Services
- DDSD Provider Enrollment & Relations
- Electronic Benefits Transfer (EBT)
- Employee Abuse Registry (EAR)
- Fraud, Waste, & Abuse
- Health Care Consolidation Oversight Act
- Intermediate Care Facility for Individuals with Intellectual Disabilities (ICF/IID)
- (-) Justice-involved Utilization of State Transitioned Healthcare (JUST Health)
- Marketplace Affordability Programs
- (-) Medicaid Transition Premium Relief Program
- National Guard Premium Assistance
- New Mexico Medicaid Estate Recovery Program
- Ordering, Referring, Prescribing Provider (ORP)
- Refugee Resettlement Program
- Rural Health Care Delivery Fund
- Small Business Health Insurance Premium Relief Initiative
- SNAP Quality Control Reviews
- State Employee Premium Assistance Program
- Sun Bucks
- Supplemental Nutrition Assistance Program (SNAP)
- Turquoise Care
No. Early Access funding is in addition to the regional planning funds. Regions that do not apply will still have access to their share during the full implementation of the regional plan. Any unspent Early Access funds are returned to the main funding pool and remain available for future use.
Applications must be submitted by the designated Accountable Entity, as defined for each region. However, multiple providers and projects may collaborate under a single submission from an accountable entity. Coordination among counties and agencies is encouraged.
The Administrative Office of the Courts (AOC) has an updated list of Accountable Entity contacts on its website. For assistance connecting with regional leads, participants may email AOC directly at: aoceal@nmcourts.gov.
There are three related but distinct funding tracks:
- AOC Mini-Grants — Up to $60,000 per region, to establish planning committees and hold listening sessions.
- Early Access Regional Funding — Up to $26 million statewide, with a maximum of $2 million per region, focused on critical behavioral health needs.
- Full Regional Plans – Long-term regional planning that identifies up to five regional priorities to be submitted to the Behavioral Health Executive
Committee for approval.
Unapplied funds return to the collective pot – they are not reserved or 'escrowed' by region. Regions that skip Early Access will not be penalized when submitting complete regional plans later.
Extensions may be considered if a region formally requests additional time in writing. The Executive Committee will review requests on a case-by-case basis, balancing flexibility with the need to obligate funds before the end of FY27.
The Accountable Entity should coordinate across all counties. If one county has an immediate, critical need, other counties, nations, pueblos, and tribes are encouraged to support its submission. Funding within a region benefits the shared population.
Each region submits one consolidated application through its Accountable Entity. That application may include multiple projects, each described and budgeted separately.
Applications are due December 19, 2025
Award notifications: Week of January 26, 2026
Contracting period: February–March 2026
No. While both draw from the overall SB3 appropriation, Early Access only accelerates funding for immediate needs. Later planning funds remain available, adjusted by total allocations statewide.
Projects must fit into one or more of these critical access shortage areas:
- Crisis continuum and stabilization services
- Residential treatment or transitional housing
- MAT programs for justice-involved individuals
- Prenatal and perinatal SUD programs
For full details, see the Early Access NOFO: Here in section 2.4 on page 9.
Yes, as long as expenditures align with the NOFO scope and federal/state requirements. Leveraging other funds (e.g., AOC planning or local ARPA allocations) is encouraged.
Early Access funding may be used for infrastructure projects, such as renovations, safety improvements, or completion of existing facilities, if it aligns with priorities in a regional plan and addresses behavioral health service gaps. Projects should be already in progress, planned, or mapped out, rather than entirely new builds, and funding is intended to supplement existing investment, not fully finance large-scale new facilities. All infrastructure funding requires committee approval to ensure alignment with SB3 goals and regional priorities.
However, state funding for construction or building improvement projects requires that a county, municipality, or other arm of the state retain ownership of any building, vehicles, or other capital assets being bought or improved with public funds in order to avoid violating Article IX, Section 14 of the NM Constitution (the “anti-donation clause”). Under Art. IX, Sec. 14, private persons and entities are prohibited from receiving state funds as “a gift, an allocation or appropriation of something of value, without consideration.” Vill. of Deming v. Hosdreg Co., 1956-NMSC-111, ¶ 36, 62 N.M.
Euna Procurement/Bonfire is the State of New Mexico’s secure online portal for submitting funding applications and managing proposal documents. All BHRIA Early Access applications must be submitted through this system.
Applications for Early Access Regional Plans are submitted through the Health Care Authority Euna Procurement portal at: newmexicohsd.bonfirehub.com/opportunities/208928
This link goes directly to the opportunity titled: BHRIA371555 – Early Access Regional Plans.
Complete the following steps:
- Go to the portal link above.
- Click “Log In / Register” in the upper-right corner.
- Select “Create an Account.”
- Enter your organization and contact information.
- Verify your registration by clicking the confirmation link sent to your email.
Yes. To upload and submit your proposal, you must first create a Vendor Organization within Euna Procurement. This can be completed during registration or added later under your account profile.
Once registered and logged in, you’ll see:
- Project Title: Early Access Regional Funding
- Reference Number: BHRIA371555
- Status: Open
- Open Date: November 4, 2025 – 8:00 AM MST
- Close Date: December 19, 2025 – 11:30 PM MST
Supporting documentation, including the NOFO and Appendices A–F, can be downloaded from the Supporting Documentation section, which can be found here.
Complete the following steps:
- Log in to your account.
- Open “BHRIA371555 — Early Access Regional Plans.”
- Click “Prepare Submission.”
- Upload all required documents listed under Requested Information.
— Required file: Proposal (PDF format). - Review your uploads and click “Submit & Finalize.”
- You will receive a confirmation email once your submission is complete.
Yes. You may withdraw and resubmit updated files at any time prior to the deadline. After 11:30 PM MST on December 19, 2025, the portal will lock automatically, and no further file edits will be permitted.
For questions about eligibility, funding requirements, or attachments, please email: BHRIAsupport@hca.nm.gov
For technical support with Euna Procurement (Bonfire), please contacts us at:
support@gobonfire.com
1-800-354-8010 (Monday–Friday, 8 AM–8 PM ET)
Live Chat is available via the portal.
Additional Information More details about the Behavioral Health Reform and Investment Act (BHRIA) are available at: hca.nm.gov/about_the_department/behavioral-health-reform
Yes. HCA requires any participating pharmacy (on-site or community-based) to enroll and bill as a Medicaid pharmacy (separate from the medical provider) and to follow billing and claims processes, including all real-time or batched billing/claims requirements and prior authorization (PA) requirements (if applicable), that match current fee-for-service (FFS) processes.
Carceral facilities can bill for medications as medical claims when the medications are provided by the medical provider rather than dispensed directly from the pharmacy. For example, if a CDC purchases stock medications for Medication Assisted Treatment (MAT) and a qualified provider administers the treatment, the medications and any applicable services (e.g., evaluation or counseling) should be billed as a medical claim.
Facility staff may not transfer bulk medications into individual packages that do not meet state and federal prescribing standards (e.g., pill envelopes) for individuals to utilize upon release. Only medications that are labeled for a specific patient and fulfilled by a licensed pharmacist (including through a licensed onsite pharmacy) according to state and federal prescribing standards meet the medications-in-hand requirement.
No. Medicaid should only be billed for the portion of the bulk medication that is provided to the Medicaid member.
No. Medications must follow the Medicaid formulary, as identified by HCA’s preferred drug list (PDL). While updates to the PDL will be made on a regular basis, Medicaid-enrolled pharmacies should be up to date on covered drugs.
Yes. pharmacy providers are required to submit claims through the point-of-sale system. The point-of-sale system provides relevant drug utilization information that the pharmacist must consider before dispensing a drug. Pharmacies must follow the NM FFS Payer Sheet. The BIN for JUST Health Plus members is 028165, and pharmacy software systems must be updated accordingly so that patient profiles can reflect the new BIN. Additionally, pharmacies must have POS equipment capable of billing D.0 transactions to ensure claims can be received, processed, and sent for payment in the Turquoise Care System.
Yes. Carceral facilities with 340B-acquired medications must identify 340B participation and pricing on claims by using modifiers “UD” or “08” when billing Medicaid for the applicable medications. Please refer to Provider Supplement 20-04 for further instructions on billing for 340B-acquired medications.
HCA expects the ordering provider to determine clinical appropriateness of a new prescription. Providers have the option of overriding a “Fill too Soon” rejection. If utilization information indicates that the member has an adequate supply of the medication or that the quantity being dispensed is excessive, the pharmacist is responsible for resolving the issue by seeking an authorization to dispense the drug, if necessary.
The requirement is to provide up to a 30-day supply of the medications in-hand, as clinically appropriate except as outlined below. HCA expects prescribers to use their clinical judgement when determining the appropriate amount of medication to provide upon release.